ACP
AGN

Ashfield Capital Partners’s Allergan plc AGN Stock Holding History

Ashfield Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,232
Closed -$866K – 253
2016
Q1 		$866K Hold
3,232
– – 0.06% 156
2015
Q4 		$1.01M Hold
3,232
– – 0.07% 152
2015
Q3 		$878K Sell
3,232
-1,224
-27% -$376K 0.06% 162
2015
Q2 		$1.35M Hold
4,456
– – 0.07% 143
2015
Q1 		$1.33M Buy
+4,456
New +$1.27M 0.07% 144

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ashfield Capital Partners's AGN Position: Q2 2016 in Review

Ashfield Capital Partners sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 3,232 shares — an estimated $866K sold.

Ashfield Capital Partners first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $1.35M in Q2 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Ashfield Capital Partners reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Ashfield Capital Partners sold 3,232 Allergan plc shares in Q2 2016, an estimated $866K.
  • Ashfield Capital Partners first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Ashfield Capital Partners's Allergan plc position peaked at $1.35M in Q2 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Ashfield Capital Partners's 13F filing for Q2 2016, filed 8 Aug 2016.